(Q38050342)
Statements
Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature (English)
Aldo Airoldi
Marcello Vangeli
Luca Saverio Belli
Claudio Zavaglia
Gabriella Cordone
Maria Gentiluomo
1 February 2013